cryptotanshinone has been researched along with Invasiveness, Neoplasm in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Chen, S; Guan, L; Lai, M; Li, J; Liu, Z; Wang, H; Yu, W | 1 |
Jiang, G; Li, W; Liu, J; Liu, L; Owusu, L; Ren, B; Tang, Y; Zhang, J; Zhang, L | 1 |
Fan, HN; Jiang, QK; Liu, YD; Lu, HL; Qian, Y; Wang, Y; Yang, LY; Zhu, XJ | 1 |
Cai, G; Chen, C; Guo, J; Kong, L; Li, S; Yin, G; Yu, W; Zhang, C; Zhang, W; Zhu, J | 1 |
Chen, C; Duanmu, J; Gu, J; Li, C; Liu, Z; Tao, J; Wu, Y; Xiong, B; Yang, A; Yin, X; Zhang, L | 1 |
Feng, Q; He, B; Xiong, Y; Yang, L; Ye, T; Yu, L; Zhang, Y; Zhao, L; Zhu, S; Zhu, Y | 1 |
6 other study(ies) available for cryptotanshinone and Invasiveness, Neoplasm
Article | Year |
---|---|
LYW-6, a novel cryptotanshinone derived STAT3 targeting inhibitor, suppresses colorectal cancer growth and metastasis.
Topics: Animals; Apoptosis; Caco-2 Cells; Cell Cycle; Cell Movement; Cell Proliferation; Colorectal Neoplasms; HCT116 Cells; Humans; Mice, Inbred ICR; Mice, Inbred NOD; Mice, SCID; Molecular Docking Simulation; Neoplasm Invasiveness; Neoplasm Metastasis; Phenanthrenes; Protein Binding; STAT3 Transcription Factor; Toxicity Tests, Acute; Xenograft Model Antitumor Assays | 2020 |
Anti-tumor and chemosensitization effects of Cryptotanshinone extracted from Salvia miltiorrhiza Bge. on ovarian cancer cells in vitro.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; DNA Damage; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Molecular Structure; Neoplasm Invasiveness; Ovarian Neoplasms; Phenanthrenes; Plant Extracts; Salvia miltiorrhiza | 2017 |
Cryptotanshinone sensitizes antitumor effect of paclitaxel on tongue squamous cell carcinoma growth by inhibiting the JAK/STAT3 signaling pathway.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Humans; Janus Kinases; Models, Biological; Neoplasm Invasiveness; Paclitaxel; Phenanthrenes; Signal Transduction; STAT3 Transcription Factor; Tongue Neoplasms | 2017 |
A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy.
Topics: Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Cell Movement; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Phenanthrenes; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; STAT3 Transcription Factor; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2018 |
Cryptotanshinone inhibits the growth and invasion of colon cancer by suppressing inflammation and tumor angiogenesis through modulating MMP/TIMP system, PI3K/Akt/mTOR signaling and HIF-1α nuclear translocation.
Topics: Active Transport, Cell Nucleus; Anti-Inflammatory Agents; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Drugs, Chinese Herbal; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunomodulation; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neovascularization, Pathologic; Oncogene Protein v-akt; Phenanthrenes; Phosphatidylinositol 3-Kinases; Salvia miltiorrhiza; Signal Transduction; Tissue Inhibitor of Metalloproteinase-1; TOR Serine-Threonine Kinases | 2018 |
Cryptotanshinone induces melanoma cancer cells apoptosis via ROS-mitochondrial apoptotic pathway and impairs cell migration and invasion.
Topics: Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Shape; Cell Survival; G2 Phase Cell Cycle Checkpoints; Humans; Melanoma; Mitochondria; Neoplasm Invasiveness; Phenanthrenes; Reactive Oxygen Species; Signal Transduction; Skin Neoplasms; Tumor Stem Cell Assay | 2016 |